Corrigendum to “Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet”[Eur. J. Pharmacol. 995 (2025) 177419]

Adiponectin Signaling as an Immunometabolic Regulator in COVID-19: Mechanistic Insights and Therapeutic Potential

Role of insulin-like growth factor-1/2 and related signaling in parkinson’s disease

The potential role of metformin in multiple sclerosis: good or bad, and what’s the lesson

Autophagy in ischemic stroke: from cellular survival mechanism to pathological damage

Targeting of the PI3K/AKT/mTOR signaling pathway in the neurovascular interface in both Alzheimer's disease and atherosclerosis: The potential nexus